BioNexus Gene Lab (BGLC)
BioNexus Gene Lab (BGLC) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- BGLC last traded at $0.68 on 2026-11-19, -7.29% for the session.
- BioNexus Gene Lab: market cap $1.64M, revenue $630.67K over the last four quarters.
- Over the past year BGLC returned -84.99%, with a year-to-date return of -82.78%.